טוען...
Frailty, Mycophenolate Reduction, and Graft Loss in Kidney Transplant Recipients
BACKGROUND: Mycophenolate mofetil (MMF) side effects often prompt dose reduction or discontinuation, and this MMF dose reduction (MDR) can lead to rejection and possibly graft loss. Unfortunately, little is known about what factors might cause or contribute to MDR. Frailty, a measure of physiologic...
שמור ב:
| הוצא לאור ב: | Transplantation |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4382409/ https://ncbi.nlm.nih.gov/pubmed/25393156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0000000000000444 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|